The UK's health service is heading for a severe financial shortfall and will have to consider limiting spending, including on …

GlaxoSmithKline will increase its reach into emerging markets with a new deal to co-market generics with Dr. Reddy’s.The Indian company …
Plavix is to face competition from six generics in Europe, potentially decimating sales of Sanofi-Aventis' brand in the region. Plavix …
The European Commission has opted not to press ahead with developing a Directive on Good Manufacturing Practices for ‘certain’ pharmaceutical …
A new PR body has been launched and tasked with shedding some light on how to promote healthcare clients online …
Lilly is launching a new web portal which it hopes will attract drug discovery researchers with promising new compounds. The …
Pharmafocus presents a round-up of developments in the contract research sector, including CBI's acquisition of a peptide specialist, MDS Pharma …
Novartis is ready to press ahead with clinical trials of its candidate vaccine against influenza (A)H1N1, having completed manufacturing of …
The UK has always been one of the world's leaders in drug discovery, with around half of all major medicines …
Irish contract research organisation Icon will manage clinical trial set-up and management for Lilly's European trials in a deal that …
Patients with early stage Alzheimer's disease will still be denied access to drug treatment after NICE decided to retain its …
The new health secretary Andy Burnham has promised a 'deep clean' of the NHS' priorities, with a further move away …
Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …
Schering-Plough has opened a new pharmaceutical manufacturing facility in Oss, the Netherlands, to help meet demand for the drugmakers' injectable …
The Department of Health has insisted there will be no "material change" to the UK's preparations for swine flu. The …
Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …

The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …
The big pharma model is broken, and one of the ways drug development companies are going to fix it is …